Skip to main content
Clinical Trials/EUCTR2016-002197-13-ES
EUCTR2016-002197-13-ES
Active, not recruiting
Phase 1

IMPLICATION OF TWO ANESTHETIC TECHNIQUES: SEVOFLURANE VERSUS PROPOFOL TO REDUCE BLOOD LOSS IN ORTHOGNATHIC SURGERY

Servicio de Anestesiología y Reanimación0 sitesOctober 26, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Servicio de Anestesiología y Reanimación
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Servicio de Anestesiología y Reanimación

Eligibility Criteria

Inclusion Criteria

  • Patients \= 18 and \= 65 years old.
  • Classification ASA (American Society of Anesthesiologists) I or II.
  • orthognathic surgery scheduled bimaxillary
  • Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 100
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Patients who do not wish to consent to participate in the study.
  • Hemodynamic instability determined by the need for continuous infusion of inotropic or vasopressor.
  • Severe heart disease (Grades III and IV, NYHA)
  • Kidney disease (creatinine clearance \= 30 mL / min)
  • Liver disease (Grade C Child\-Pugh).
  • Diabetes Mellitus Type I or II compensated or decompensated.
  • Previous surgery in the surgical field including orthognathic surgery.
  • Patients with treatments or diseases affecting the coagulation cascade or platelet aggregation.

Outcomes

Primary Outcomes

Not specified

Similar Trials